Leukemia: all 5,475 studies
Page 21 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Effects of Home-Based Exercise Program in Children After Acute Lymphoblastic LeukemiaCompletedNCT06664736Not applicable
- Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLActive, not recruitingNCT06578247Phase 3
- Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched DonorWithdrawnNCT06572631Phase 1
- Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Active, not recruitingNCT06547944Phase 1
- Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual DiseaseWithdrawnNCT06522373Phase 1
- Technology-Assisted Yoga and Exercise on Neuropathy and Pain in Children With LeukemiaCompletedNCT06512012Not applicable
- A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic MalignanciesCompletedNCT06492304Phase 1/2
- Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With HemoblastosisActive, not recruitingNCT06475820Phase 2/3
- FLT3 Clonal Evolution in Patients With Acute Myeloid LeukemiaCompletedNCT06463639
- Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense ChemotherapyTerminatedNCT06449482Phase 1/2
- Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/RefractoryCompletedNCT06429670
- Exercise As Intervention in Chronic Lymphocytic LeukemiaActive, not recruitingNCT06396611Not applicable
- CD155 Expression in Acute Myeloid LeukemiaCompletedNCT06369662
- A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart ReviewWithdrawnNCT06362031
- Providing Web-based Training to Parents Of Children With LeukemiaCompletedNCT06357585Not applicable
- DEC-C and Thioguanine for R/R AMLWithdrawnNCT06351306Phase 2
- Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic LeukemiaCompletedNCT06338020Not applicable
- Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell TransplantWithdrawnNCT06337331Phase 2
- False Positive Peripheral Blood Culture in Children With Leukaemia: A Prevalence StudyCompletedNCT06336837
- YASU Research Registry: For Young Adults With CancerTerminatedNCT06275854
- Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWithdrawnNCT06247540Phase 2
- The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid LeukaemiaActive, not recruitingNCT06233890
- Real-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)CompletedNCT06211153
- Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)WithdrawnNCT06210750Phase 2
- A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i TherapiesWithdrawnNCT06205290Phase 3
- Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) PatientsWithdrawnNCT06180863Phase 2
- Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCTStatus unknownNCT06177561Not applicable
- Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
- Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]TerminatedNCT06150040Phase 1/2
- Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims DatabaseCompletedNCT06148493
- Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCTActive, not recruitingNCT06141304Phase 2
- CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT06128044Phase 1
- A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid LeukemiaWithdrawnNCT06113289Phase 1/2
- Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AMLTerminatedNCT06110208Early Phase 1
- Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic LeukemiaActive, not recruitingNCT06110182
- HCT With PTCy in Higher-risk MDSActive, not recruitingNCT06098313Phase 2
- Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced-Nausea and Vomiting in Children With LeukemiaCompletedNCT06095726Not applicable
- Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HDCompletedNCT06093334Not applicable
- Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic LeukemiaWithdrawnNCT06085638Phase 1/2
- Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)TerminatedNCT06068868Phase 1
- Comorbidity Burden and Use of Concomitant Medications at CML DiagnosisCompletedNCT06042660
- Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology PatientsCompletedNCT06026046Not applicable
- NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After ChemotherapyActive, not recruitingNCT06024031Phase 2
- A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous CladribineTerminatedNCT06021600Phase 1
- Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid LeukemiaWithdrawnNCT06007911Phase 1
- Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell NeoplasmCompletedNCT06006403Phase 1/2
- HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisActive, not recruitingNCT06001385Phase 2
- Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic LeukemiaActive, not recruitingNCT05993949Phase 1
- Analysis of CMTM6 Expression in Patients With Acute Myeloid LeukemiaCompletedNCT05988047
- Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell TransplantTerminatedNCT05984199Phase 1/2
- Study of Tazemetostat in Lymphoid MalignanciesTerminatedNCT05983965Phase 1
- The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3CompletedNCT05969600
- A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaWithdrawnNCT05961696Phase 1
- Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) PatientsStatus unknownNCT05951855Phase 2
- Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid LeukemiaWithdrawnNCT05943314Not applicable
- Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid LeukemiaCompletedNCT05941585Not applicable
- Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell TherapyWithdrawnNCT05936229Phase 1/2
- Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCTCompletedNCT05928156Not applicable
- Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile NeutropeniaCompletedNCT05926063Phase 4
- Mucorales PCR Screening in At-risk Hematology PatientsCompletedNCT05925660Not applicable
- Expanded Access Program for RevumenibNo longer availableNCT05918913
- High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHDWithdrawnNCT05895201Phase 1/2
- Real-World Disease Management and Outcomes in Chronic Myeloid LeukaemiaCompletedNCT05893836
- A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)Active, not recruitingNCT05885464Phase 1/2
- A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic LeukemiaActive, not recruitingNCT05883956Phase 3
- Integrated Actionable Aging Assessment for Cancer Patients PilotActive, not recruitingNCT05871008Not applicable
- CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)WithdrawnNCT05854966Phase 2
- Study of CT071 Injection in RRMM or PPCLActive, not recruitingNCT05838131Early Phase 1
- Registry of Relapsed/Refractory T-cell Acute Lymphoblastic LeukemiaStatus unknownNCT05832125
- Oncology Care at Home for BMT and CAR-TCompletedNCT05826288Not applicable
- Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older PatientsActive, not recruitingNCT05823571Phase 1
- Study of miRNA-155 in Acute LeukemiaStatus unknownNCT05809050
- Anti-mullerian Hormone in Acute Lymphoblastic LeukemiaStatus unknownNCT05793463
- GilteRInf 2022 Study (Gilteritinib Related Infections)Status unknownNCT05791890
- Observational Study of People Living With HIV Treated With CD19-directed CAR T CellCompletedNCT05784415
- Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid TumorsCompletedNCT05775406Phase 1
- Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia TreatmentCompletedNCT05774990
- Clinical Significance of Occult Central Nervous System LocalizationStatus unknownNCT05772000
- Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell ImmunotherapyCompletedNCT05763563Not applicable
- A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid LeukemiaCompletedNCT05743465
- HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWithdrawnNCT05740449Phase 1/2
- M-PTCy vs BuCy in Haploidentical HSCT for Acute LeukemiaStatus unknownNCT05739630Phase 2/3
- Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent LineCompletedNCT05734053
- Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT05722171Early Phase 1
- Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid LeukemiaWithdrawnNCT05720988Phase 1
- A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeStatus unknownNCT05703204Phase 1
- Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCTCompletedNCT05696457Not applicable
- Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic TumorsActive, not recruitingNCT05683353
- Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)TerminatedNCT05682170Phase 1/2
- How Effective is the Dose-graded Aerobic Training in Children Survivors of Acute Lymphoblastic Leukemia?CompletedNCT05679817Not applicable
- Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic LeukemiaCompletedNCT05676710Phase 1
- Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT05673057Phase 1
- Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in PediatricsStatus unknownNCT05664230
- Clinical Study of Venetoclax Combined with CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT05659992Phase 2
- Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.TerminatedNCT05645744
- Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous LeukemiaStatus unknownNCT05638763Phase 2
- US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid LeukemiaNo longer availableNCT05627466
- ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AMLWithdrawnNCT05622591Phase 1
- French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML PatientsCompletedNCT05619978
- CAR-T Cells in the Treatment of Malignant Hematological TumorsStatus unknownNCT05619861Not applicable